These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
98 related items for PubMed ID: 24220313
1. Tongxinluo decreases apoptosis of mesenchymal stem cells concentration-dependently under hypoxia and serum deprivation conditions through the AMPK/eNOS pathway. Li N, Yang YJ, Cui HH, Zhang Q, Jin C, Qian HY, Dong QT, Zhang H. J Cardiovasc Pharmacol; 2014 Mar; 63(3):265-73. PubMed ID: 24220313 [Abstract] [Full Text] [Related]
2. Tongxinluo exerts protective effects via anti-apoptotic and pro-autophagic mechanisms by activating AMPK pathway in infarcted rat hearts. Li Q, Li N, Cui HH, Tian XQ, Jin C, Chen GH, Yang YJ. Exp Physiol; 2017 Apr 01; 102(4):422-435. PubMed ID: 28150462 [Abstract] [Full Text] [Related]
3. Atorvastatin prevents mesenchymal stem cells from hypoxia and serum-free injury through activating AMP-activated protein kinase. Dong Q, Yang Y, Song L, Qian H, Xu Z. Int J Cardiol; 2011 Dec 15; 153(3):311-6. PubMed ID: 20832877 [Abstract] [Full Text] [Related]
4. Tongxinluo reduces myocardial no-reflow and ischemia-reperfusion injury by stimulating the phosphorylation of eNOS via the PKA pathway. Li XD, Yang YJ, Geng YJ, Jin C, Hu FH, Zhao JL, Zhang HT, Cheng YT, Qian HY, Wang LL, Zhang BJ, Wu YL. Am J Physiol Heart Circ Physiol; 2010 Oct 15; 299(4):H1255-61. PubMed ID: 20693395 [Abstract] [Full Text] [Related]
5. [Atorvastatin protects swine bone marrow mesenchymal stem cells from apoptosis through AMPK but not PI3K/Akt pathway]. Song L, Yang YJ, Dong QT, Qian HY, Xu H, Meng XM, Tang Y. Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Nov 15; 39(11):1033-8. PubMed ID: 22336458 [Abstract] [Full Text] [Related]
6. Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats. Zhang CX, Pan SN, Meng RS, Peng CQ, Xiong ZJ, Chen BL, Chen GQ, Yao FJ, Chen YL, Ma YD, Dong YG. Clin Exp Pharmacol Physiol; 2011 Jan 15; 38(1):55-62. PubMed ID: 21083698 [Abstract] [Full Text] [Related]
7. Induction of autophagy by Tongxinluo through the MEK/ERK pathway protects human cardiac microvascular endothelial cells from hypoxia/reoxygenation injury. Cui H, Li X, Li N, Qi K, Li Q, Jin C, Zhang Q, Jiang L, Yang Y. J Cardiovasc Pharmacol; 2014 Aug 15; 64(2):180-90. PubMed ID: 24705173 [Abstract] [Full Text] [Related]
8. Autophagy activation: a novel mechanism of atorvastatin to protect mesenchymal stem cells from hypoxia and serum deprivation via AMP-activated protein kinase/mammalian target of rapamycin pathway. Zhang Q, Yang YJ, Wang H, Dong QT, Wang TJ, Qian HY, Xu H. Stem Cells Dev; 2012 May 20; 21(8):1321-32. PubMed ID: 22356678 [Abstract] [Full Text] [Related]
9. Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2. Xu R, Chen J, Cong X, Hu S, Chen X. J Cell Biochem; 2008 Jan 01; 103(1):256-69. PubMed ID: 17497701 [Abstract] [Full Text] [Related]
10. Protein kinase A-mediated cardioprotection of Tongxinluo relates to the inhibition of myocardial inflammation, apoptosis, and edema in reperfused swine hearts. Li XD, Yang YJ, Cheng YT, Dou KF, Tian Y, Meng XM. Chin Med J (Engl); 2013 Jan 01; 126(8):1469-79. PubMed ID: 23595379 [Abstract] [Full Text] [Related]
11. Macrophage migration inhibitory factor induces autophagy to resist hypoxia/serum deprivation-induced apoptosis via the AMP-activated protein kinase/mammalian target of rapamycin signaling pathway. Xia W, Hou M. Mol Med Rep; 2016 Mar 01; 13(3):2619-26. PubMed ID: 26847932 [Abstract] [Full Text] [Related]
12. Hypoxic preconditioning protects cardiomyocytes against hypoxia/reoxygenation injury through AMPK/eNOS/PGC-1α signaling pathway. Hu L, Zhou L, Wu X, Liu C, Fan Y, Li Q. Int J Clin Exp Pathol; 2014 Mar 01; 7(11):7378-88. PubMed ID: 25550773 [Abstract] [Full Text] [Related]
13. Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole. Liu Y, Oh SJ, Chang KH, Kim YG, Lee MY. Biochem Pharmacol; 2013 Oct 01; 86(7):914-25. PubMed ID: 23876340 [Abstract] [Full Text] [Related]
14. Tongxinluo-pretreated mesenchymal stem cells facilitate cardiac repair via exosomal transfer of miR-146a-5p targeting IRAK1/NF-κB p65 pathway. Xiong Y, Tang R, Xu J, Jiang W, Gong Z, Zhang L, Ning Y, Huang P, Xu J, Chen G, Li X, Hu M, Xu J, Wu C, Jin C, Li X, Qian H, Yang Y. Stem Cell Res Ther; 2022 Jul 07; 13(1):289. PubMed ID: 35799283 [Abstract] [Full Text] [Related]
15. Effects of Tongxinluo-facilitated cellular cardiomyoplasty with autologous bone marrow-mesenchymal stem cells on postinfarct swine hearts. Qian HY, Yang YJ, Huang J, Gao RL, Dou KF, Yang GS, Li JJ, Shen R, He ZX, Lu MJ, Zhao SH. Chin Med J (Engl); 2007 Aug 20; 120(16):1416-25. PubMed ID: 17825171 [Abstract] [Full Text] [Related]
16. Tongxinluo promotes mesenchymal stem cell tube formation in vitro. Hu XY, Wang WX, Yu MJ, Liu XB, Wu RR, Gao F, Huang X, Cao J, Xie XJ, Wang JA. J Zhejiang Univ Sci B; 2011 Aug 20; 12(8):644-51. PubMed ID: 21796805 [Abstract] [Full Text] [Related]
17. Nectandrin B activates endothelial nitric-oxide synthase phosphorylation in endothelial cells: role of the AMP-activated protein kinase/estrogen receptor α/phosphatidylinositol 3-kinase/Akt pathway. Hien TT, Oh WK, Nguyen PH, Oh SJ, Lee MY, Kang KW. Mol Pharmacol; 2011 Dec 20; 80(6):1166-78. PubMed ID: 21940786 [Abstract] [Full Text] [Related]
18. Tongxinluo Attenuates Myocardiac Fibrosis after Acute Myocardial Infarction in Rats via Inhibition of Endothelial-to-Mesenchymal Transition. Yin Y, Zhang Q, Zhao Q, Ding G, Wei C, Chang L, Li H, Bei H, Wang H, Liang J, Jia Z. Biomed Res Int; 2019 Dec 20; 2019():6595437. PubMed ID: 31317035 [Abstract] [Full Text] [Related]
19. Acute exercise induce endothelial nitric oxide synthase phosphorylation via Akt and AMP-activated protein kinase in aorta of rats: Role of reactive oxygen species. Barbosa VA, Luciano TF, Marques SO, Vitto MF, Souza DR, Silva LA, Santos JP, Moreira JC, Dal-Pizzol F, Lira FS, Pinho RA, De Souza CT. Int J Cardiol; 2013 Sep 10; 167(6):2983-8. PubMed ID: 22989604 [Abstract] [Full Text] [Related]
20. Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase. Wang Y, Huang Y, Lam KS, Li Y, Wong WT, Ye H, Lau CW, Vanhoutte PM, Xu A. Cardiovasc Res; 2009 Jun 01; 82(3):484-92. PubMed ID: 19251722 [Abstract] [Full Text] [Related] Page: [Next] [New Search]